Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis | MicrobiomeTrials
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2019-02-19Est. Completion: 2027-06-01
Enrollment target: 56 participants
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States